The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against ...

Endocrine and combination ribociclib-resistant cancer cells and fibroblasts (MRC5) were labeled with lentivirus to express a distinct fluorescent protein for monitoring each population’s growth when ...